Smith & Nephew SNATS
Yahoo Finance • 3 months ago
3 UK Stocks That Might Be Undervalued By Up To 49.8%
The London markets have recently experienced declines, with the FTSE 100 index closing lower due to weak trade data from China and a general dip in global economic confidence. Amid these challenging conditions, identifying undervalued stoc... Full story
Yahoo Finance • 4 months ago
Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and... Full story
Yahoo Finance • 9 months ago
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D... Full story
Yahoo Finance • 9 months ago
Charles Brandes Bolsters Portfolio with a Strategic Emphasis on Corteva Inc
Insight into the Investment Moves of a Value Investing Stalwart Charles Brandes (Trades, Portfolio), a seasoned value investor and founder of Brandes Investment Partners, has made notable changes to his investment portfolio in the fourth... Full story
Yahoo Finance • 9 months ago
Smith & Nephew plc's (LON:SN.) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Most readers would already be aware that Smith & Nephew's (LON:SN.) stock increased significantly by 22% over the past three months. However, in this article, we decided to focus on its weak fundamentals, as long-term financial performance... Full story
Yahoo Finance • 11 months ago
Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?
Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith & Nephew's UK£10.21 share price signals that it might be 40% undervalued The US$12.68 analyst price target for SN. is 26% less... Full story
Yahoo Finance • last year
Boeing, CyberArk Lead 5 Stocks Near Buy Points
The market rally is going strong, but watch out for a potential pullback. Top stocks near buy points include Boeing and CyberArk.... Full story
Yahoo Finance • last year
Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform
LONDON, May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digital surgery portfolio – Personalized Plann... Full story
Yahoo Finance • 2 years ago
New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
LONDON, March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsular Tonsillectomy (CIT) technique can le... Full story
Yahoo Finance • 2 years ago
Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
An uncompromising commitment to freedom of movement LONDON, March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils "Precision in Motion", a franchise-level value proposition s... Full story
Yahoo Finance • 2 years ago
It may not be sprinting ahead, but Smith & Nephew is still in the race – so don’t write it off
Smith & Nephew remains a source of disappointment, as our thesis that the orthopaedics, wound care and sports medicines specialist could be an ideal Covid-19 recovery play is yet to really prove itself. A paper loss of 16pc over two years... Full story
Yahoo Finance • 2 years ago
Smith & Nephew plc (NYSE:SNN) Q4 2022 Earnings Call Transcript
Smith & Nephew plc (NYSE:SNN) Q4 2022 Earnings Call Transcript February 21, 2023 Deepak Nath: So good morning, and welcome to the Smith & Nephew Full Year 2022 Results Presentation. I'm Deepak Nath, Chief Executive Officer. And joining me... Full story
Yahoo Finance • 2 years ago
15 Largest Orthopedic Companies in the World
In this article, we will take a look at the 15 largest orthopedic companies in the world. If you want to see more companies in this selection, go to the 5 Largest Orthopedic Companies in the World. The orthopedic industry has staged a com... Full story
Yahoo Finance • 2 years ago
Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution
LONDON, Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplast... Full story
Yahoo Finance • 2 years ago
10 Best International Stocks to Buy Now
In this article, we discuss 10 best international stocks to buy now. If you want to see more stocks in this selection, check out 5 Best International Stocks to Buy Now. Markets are swinging wildly, and the rally in the last week is alread... Full story
Yahoo Finance • 2 years ago
Another day, another profits warning – but here's why you should stick by Smith & Nephew
Surgeons Oh dear. Just when it seemed like Smith & Nephew was making progress, the FTSE 100 company has dished out another profits warning. As a result, shares in the orthopaedics, wound care and sports medicine specialist are limping lo... Full story
Yahoo Finance • 2 years ago
Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting
LONDON, July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robust line-up featuring several of its advanced joint repair solutions and a wide array of educational acti... Full story
Yahoo Finance • 2 years ago
SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS
LONDON, June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds International. The article proposes that an estimated 3.5 b... Full story
Yahoo Finance • 2 years ago
Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION
LONDON, June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces that the first total hip arthroplasty (THA) procedure using RI.HIP MODELER, a new preoperative spinopelvic assess... Full story
Yahoo Finance • 3 years ago
11 Best UK Stocks to Buy Now
In this article, we discuss 11 best UK stocks to buy now. If you want to see some more stocks from our selection, click 5 Best UK Stocks to Buy Now. Market experts and analysts from advisory firms believe that the underlying economic reco... Full story
